These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12088761)

  • 1. Effect of experimental hypoalbuminemia on the plasma protein binding of tolmetin.
    Pérez-Urizar J; Flores-Murrieta FJ; Castañeda-Hernández G
    Life Sci; 2002 Jul; 71(9):1015-22. PubMed ID: 12088761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible binding of tolmetin, zomepirac, and their glucuronide conjugates to human serum albumin and plasma.
    Ojingwa JC; Spahn-Langguth H; Benet LZ
    J Pharmacokinet Biopharm; 1994 Feb; 22(1):19-40. PubMed ID: 8027947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and irreversible binding of tolmetin and its glucuronic acid esters in the elderly.
    Munafo A; Hyneck ML; Benet LZ
    Pharmacology; 1993 Nov; 47(5):309-17. PubMed ID: 8265721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein binding of tolmetin.
    Selley ML; Madsen BW; Thomas J
    Clin Pharmacol Ther; 1978 Dec; 24(6):694-705. PubMed ID: 710027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and mass-spectrometric characterization of human serum albumins modified by covalent binding of two non-steroidal anti-inflammatory drugs: tolmetin and zomepirac.
    Zia-Amirhosseini P; Ding A; Burlingame AL; McDonagh AF; Benet LZ
    Biochem J; 1995 Oct; 311 ( Pt 2)(Pt 2):431-5. PubMed ID: 7487878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivity of tolmetin glucuronide with human serum albumin. Identification of binding sites and mechanisms of reaction by tandem mass spectrometry.
    Ding A; Zia-Amirhosseini P; McDonagh AF; Burlingame AL; Benet LZ
    Drug Metab Dispos; 1995 Mar; 23(3):369-76. PubMed ID: 7628303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irreversible binding of tolmetin to macromolecules via its glucuronide: binding to blood constituents, tissue homogenates and subcellular fractions in vitro.
    Ojingwa JC; Spahn-Langguth H; Benet LZ
    Xenobiotica; 1994 Jun; 24(6):495-506. PubMed ID: 7975715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for covalent binding of acyl glucuronides to serum albumin via an imine mechanism as revealed by tandem mass spectrometry.
    Ding A; Ojingwa JC; McDonagh AF; Burlingame AL; Benet LZ
    Proc Natl Acad Sci U S A; 1993 May; 90(9):3797-801. PubMed ID: 8483897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible binding of tolmetin glucuronic acid esters to albumin in vitro.
    Munafo A; McDonagh AF; Smith PC; Benet LZ
    Pharm Res; 1990 Jan; 7(1):21-7. PubMed ID: 2300531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of induced hypoalbuminemia on distribution, total clearance and unbound clearance of piroxicam in vivo in the rat.
    Troconiz JI; Lopez-Bustamante LG; Fos D
    Eur J Drug Metab Pharmacokinet; 1993; 18(2):165-71. PubMed ID: 8243500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free fraction change with differing volume ratios in equilibrium dialysis: cases of non-linear drug-protein binding.
    Behm HL; Wagner JG
    J Pharm Pharmacol; 1981 May; 33(5):283-9. PubMed ID: 6116775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition and irreversible plasma protein binding of tolmetin in humans.
    Hyneck ML; Smith PC; Munafo A; McDonagh AF; Benet LZ
    Clin Pharmacol Ther; 1988 Jul; 44(1):107-14. PubMed ID: 3390998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on disposition and metabolism of tolmetin, a new anti-inflammatory agent, in rats and mice. I. Absorption, distribution, and excrection of [14C]tolmetin radioactivity.
    Hashimoto M; Miyazaki H; Fujii T; Nambu K; Tanaka K
    Drug Metab Dispos; 1979; 7(1):14-9. PubMed ID: 35320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of sex on the pharmacokinetics of tolmetin in the rat.
    Jiménez M; Pérez-Urizar J; Flores-Murrieta FJ
    J Pharmacol Toxicol Methods; 1999 Oct; 42(2):103-5. PubMed ID: 10924894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible binding of zomepirac to plasma protein in vitro and in vivo.
    Smith PC; McDonagh AF; Benet LZ
    J Clin Invest; 1986 Mar; 77(3):934-9. PubMed ID: 3949982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic study of tolmetin in the rat.
    Sabater J; Domenéch J; Obach R
    Arzneimittelforschung; 1992 Jul; 42(7):950-3. PubMed ID: 1418060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced covalent binding of tolmetin to proteins in humans after multiple dosing.
    Zia-Amirhosseini P; Ojingwa JC; Spahn-Langguth H; McDonagh AF; Benet LZ
    Clin Pharmacol Ther; 1994 Jan; 55(1):21-7. PubMed ID: 8299313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption and excretion of tolemetin in man.
    Cressman WA; Wortham GF; Plostnieks J
    Clin Pharmacol Ther; 1976 Feb; 19(2):224-33. PubMed ID: 1261159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covalent binding of zomepirac glucuronide to proteins: evidence for a Schiff base mechanism.
    Smith PC; Benet LZ; McDonagh AF
    Drug Metab Dispos; 1990; 18(5):639-44. PubMed ID: 1981713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the metabolism of tolmetin to the chemically reactive acyl-coenzyme A thioester intermediate in rats.
    Olsen J; Li C; Skonberg C; Bjørnsdottir I; Sidenius U; Benet LZ; Hansen SH
    Drug Metab Dispos; 2007 May; 35(5):758-64. PubMed ID: 17303625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.